Neogen Chemicals Ltd. (NEOGEN) AI Stock Analysis

• Market Cap: ₹31.13B
• Dividend Yield: 0.09%
• Average Volume (3M): 9.36K
• Price to Earnings (P/E): 211.5
• Beta (1Y): 1.37
• Revenue Growth: 8.44%
• EPS Growth: -35.59%
• Country: IN
• Employees: 588
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 1.40
• Shares Outstanding: 26,381,674
• 10 Day Avg. Volume: 1,157
• 30 Day Avg. Volume: 9,357
• PEG Ratio: -22.51
• Price to Book (P/B): 5.41
• Price to Sales (P/S): 5.49
• P/FCF Ratio: -35.07
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹2,001.00
• Price Target Upside: 72.96% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): 10.47
• Revenue Forecast (FY): ₹8.47B

• Rating: 61 Neutral
• Price Target: ₹1,245.00 ▲(7.62% Upside)
• Action: Reiterated Date: 02/27/26
• Date: Action: Reiterated 02/27/26

The score is primarily weighed down by expensive valuation (very high P/E) and weaker cash-flow quality despite solid revenue growth. Technicals are supportive, with the stock above key moving averages and positive momentum indicators, partially offsetting financial risks from low net margins and higher leverage.

Positive Factors

Revenue growth & improving margins

Consistent revenue growth alongside improving EBIT and EBITDA margins indicates expanding demand and better operational efficiency. Over the next 2–6 months this can translate into sustained operating leverage and stronger core profitability if product mix and cost discipline persist.

Negative Factors

Volatile cash flow / negative FCF

Volatile operating cash conversions and recent negative free cash flow constrain the company's ability to self-fund capital expenditure, repay debt, or invest in growth. Persistent FCF weakness raises refinancing and liquidity risk and limits strategic flexibility during downturns.

Neogen Chemicals Ltd. Business Overview & Revenue Model

Company Description

Neogen Chemicals Limited manufactures and sells specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester c...

Read more

Neogen Chemicals Limited manufactures and sells specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester c...

How the Company Makes Money

Neogen Chemicals makes money primarily by manufacturing and selling specialty chemical intermediates. Its revenue is generated through (1) sale of bromine-based intermediates and related specialty chemicals to customers in pharma, agrochemical, an...

Read more

Neogen Chemicals makes money primarily by manufacturing and selling specialty chemical intermediates. Its revenue is generated through (1) sale of bromine-based intermediates and related specialty chemicals to customers in pharma, agrochemical, an...

Neogen Chemicals Ltd. Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	8.00B	7.78B	6.91B	6.86B	4.87B	3.36B
Gross Profit	3.69B	3.54B	1.42B	2.98B	1.40B	969.86M
EBITDA	1.37B	1.36B	1.13B	1.16B	865.60M	644.96M
Net Income	260.50M	348.30M	356.50M	499.70M	446.30M	313.30M
Balance Sheet
Total Assets	23.02B	17.47B	14.61B	10.54B	7.99B	4.92B
Cash, Cash Equivalents and Short-Term Investments	5.00B	49.60M	124.90M	967.60M	1.14B	5.10M
Total Debt	11.32B	5.97B	4.09B	3.70B	2.29B	2.22B
Total Liabilities	15.02B	9.58B	7.01B	5.71B	3.60B	3.09B
Stockholders Equity	8.00B	7.89B	7.60B	4.83B	4.39B	1.83B
Cash Flow
Free Cash Flow	-4.17B	-1.22B	-3.32B	-1.34B	-1.69B	-514.61M
Operating Cash Flow	-2.46B	1.96B	-291.50M	-303.50M	14.10M	835.70M
Investing Cash Flow	-1.13B	-3.17B	-2.16B	-944.60M	-1.46B	-1.35B
Financing Cash Flow	4.66B	1.13B	2.37B	1.00B	1.88B	507.27M

Neogen Chemicals Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1156.90
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:NEOGEN, the sentiment is Negative. The current price of 1156.9 is below the 20-day moving average (MA) of 1356.59, below the 50-day MA of 1313.05, and below the 200-day MA of 1389.61, indicating a bearish trend. The MACD of -26.22 indicates Positive momentum. The RSI at 36.05 is Neutral, neither overbought nor oversold. The STOCH value of 4.50 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:NEOGEN.

Neogen Chemicals Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BALAMINES	69 Neutral	₹33.45B	29.53	―	0.97%	-10.76%	-27.70%
ROSSARI	64 Neutral	₹22.10B	24.59	―	0.09%	15.47%	-1.72%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
NEOGEN	61 Neutral	₹31.13B	211.46	―	0.09%	8.44%	-35.59%
UFLEX	59 Neutral	₹25.94B	25.06	―	0.62%	7.44%	―
HIKAL	55 Neutral	₹19.22B	-118.51	―	0.58%	-6.72%	-86.26%
TIRUMALCHM	45 Neutral	₹21.36B	-15.05	―	0.43%	-11.11%	-340.74%